Literature DB >> 5477926

Studies of the third component of complement in synovial fluid from arthritic patients. II. Conversion and its relation to total complement.

H Hedberg, B Lundh, A B Laurell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5477926      PMCID： PMC1712733     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  17 in total

1.  Altered complement component C3A (beta-1C--beta-1A) in patients with glomerulonephritis.

Authors:  J F Soothill
Journal:  Clin Exp Immunol       Date:  1967-01       Impact factor: 4.330

2.  Electrophoretic studies of the conversion products of serum beta-1C-globulin.

Authors:  C B Laurell; B Lundh
Journal:  Immunology       Date:  1967-03       Impact factor: 7.397

3.  Alterations in human serum beta-1C-gobulin (C'3) in renal transplantation.

Authors:  C B Carpenter; T J Gill; J P Merrill; G J Dammin
Journal:  Am J Med       Date:  1967-12       Impact factor: 4.965

4.  Effect of trypsin on complement components in normal human serum.

Authors:  A B Laurell
Journal:  Acta Pathol Microbiol Scand       Date:  1968

5.  Effect of ageing of serum on consumption of antibody by beta-1C-globulin determinants; evidence for circulating breakdown products in glomerulonephritis.

Authors:  C D West; S Winter; J Forristal; N C Davis
Journal:  Clin Exp Immunol       Date:  1968-01       Impact factor: 4.330

Review 6.  Chemistry and reaction mechanisms of complement.

Authors:  H J Müller-Eberhard
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

7.  In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia.

Authors:  L D Petz; D J Fink; E A Letsky; H H Fudenberg; J Müller-Eberhard
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808

8.  Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.

Authors:  C A Alper; F S Rosen
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

9.  The conversion of C'IS to C'1 esterase by plasmin and trypsin.

Authors:  O D Ratnoff; G B Naff
Journal:  J Exp Med       Date:  1967-02-01       Impact factor: 14.307

10.  The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis.

Authors:  H J Müllerèberhard; A P Dalmasso; M A Calcott
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307
View more
  12 in total

Review 1.  Complement in the immunopathogenesis of rheumatic disease.

Authors:  Gunnar Sturfelt; Lennart Truedsson
Journal:  Nat Rev Rheumatol       Date:  2012-06-05       Impact factor: 20.543

2.  Studies of the action of some anti-inflammatory drugs on complement mediated immune haemolysis.

Authors:  K Whaley; D J Sloane
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

3.  Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.

Authors:  L H Perrin; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

4.  Complement metabolism in the seronegative arthritides.

Authors:  K Whaley; B Canesi; A Moseley; W Morrow; R Sturrock; W Mitchell; W C Dick
Journal:  Ann Rheum Dis       Date:  1974-11       Impact factor: 19.103

5.  Serum immunoglobulin and beta 1C-beta 1A globulin concentrations in juvenile rheumatoid arthritis.

Authors:  K M Goel; R W Logan; W P Barnard; R A Shanks
Journal:  Ann Rheum Dis       Date:  1974-01       Impact factor: 19.103

6.  The concentrations of the fourth component of complement and of the C1 inactivator in synovial fluid from arthritic patients.

Authors:  H Hedberg; A B Laurell
Journal:  Clin Exp Immunol       Date:  1972-06       Impact factor: 4.330

7.  Complement and immunoglobulins in synovial fluid from synovectomized patients with rheumatoid arthritis.

Authors:  O J Mellbye; B Naes; E Munthe
Journal:  Ann Rheum Dis       Date:  1976-06       Impact factor: 19.103

8.  The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.

Authors:  B E Bourke; I K Moss; P Mumford; A Horsfall; R N Maini
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

9.  Continuous production of anti-host IgG antibodies contained in circulating IgG-anti-IgG complexes.

Authors:  S A Grace; C J Elson
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

10.  C1 inactivator-C1s complexes in inflammatory joint disease.

Authors:  R D Inman; P C Harpel
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.